← Open Payments lookup

TARA SANDS: Open Payments

NPI 1992035778 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$647 in 31 payments from 10 companies in 2025. Trend: 2023 $686 · 2024 $1,106 · 2025 $647

Food & beverage: $647
CompanyPaymentsAmount
Novo Nordisk Inc4$174
ABBVIE INC.9$145
Biosense Webster, Inc.5$109
PFIZER INC.3$55
Otsuka America Pharmaceutical, Inc.3$48
Lilly USA, LLC2$33
Exact Sciences Corporation2$30
Gilead Sciences, Inc.1$21
Bayer Healthcare Pharmaceuticals Inc.1$17
AstraZeneca Pharmaceuticals LP1$15

Products named: CARTO 3, UBRELVY, ELIQUIS, REXULTI, QULIPTA, MOUNJARO, Ozempic, Cologuard Collection Kit.

Industry payments across NE — which companies pay providers there.